16 Followers on Owler
DBV is a France-based biopharmaceutical company that develops and commercializes epicutaneous immunotherapy products for patients with food allergies... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights
DBV is a France-based biopharmaceutical company that develops and commercializes epicutaneous immunotherapy products for patients with food allergies... Read more
DBV Technologies CEO: Daniel Tasse

CEO

Daniel Tasse

CEO Approval Rating

88/100

2002

PublicNASDAQDBVT

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
2836 NAICS listing

Annual Revenue
$5.8M
Employees
125
Funding
$338M
Investments
1

News

Product Launch
Feb 13, 2026
Yahoo
DBV Technologies Details Viaskin Peanut BLA Timeline, VITESSE Data and Launch Plans at Conference

DBV Technologies Competitors

1Aimmune
2Agios
3ITI
4Dbversity
5ESSA
6Array BioPharma
7Exelixis
8Diffusion Pharmaceuticals
9TESARO
10Novo Nordisk
Unlock 15 + competitors

Trending Companies